(Q36511808)

14 August 2017

1 reference

title

Animal models of anxiety and the development of novel anxiolytic drugs (English)

1 reference

14 August 2017

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

27 October 2022

author name string

D. J. Sanger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1678541

27 October 2022

G. Perrault

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1678541

27 October 2022

E. Morel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1678541

27 October 2022

D. Joly

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1678541

27 October 2022

B. Zivkovic

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1678541

27 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1678541

27 October 2022

publication date

1 January 1991

1 reference

full work available at URL

14 August 2017

https://api.elsevier.com/content/article/PII:027858469190082C?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

https://api.elsevier.com/content/article/PII:027858469190082C?httpAccept=text/plain

27 October 2022

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

Progress in Neuro-Psychopharmacology & Biological Psychiatry

27 October 2022

published in

1 reference

14 August 2017

15

1 reference

14 August 2017

2

1 reference

14 August 2017

205-212

1 reference

Behavioural effects of the benzodiazepine receptor partial agonist RO 16-6028 in mice.

14 August 2017

2

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

Lack of effects of 5HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat.

27 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

Buspirone: Action on serotonin receptors in calf hippocampus

27 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

27 October 2022

5-HT and anxiety

10

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist

27 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

Pharmacological and clinical studies of cyclopyrrolones: zopiclone and suriclone.

27 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

Limitations of the benzodiazepine receptor nomenclature: a proposal for a pharmacological classification as omega receptor subtypes.

27 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

Selectivity for omega-receptor subtypes as a strategy for the development of anxiolytic drugs

27 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

Ethologically-based animal models of anxiety disorders

27 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor

27 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone

27 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

Effects of drugs on punished behavior: pre-clinical test for anxiolytics

27 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

Demonstration of the partial agonist profiles of Ro 16-6028 and Ro 17-1812 in mice in vivo.

27 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

Further investigation of the stimulus properties of chlordiazepoxide and zolpidem. Agonism and antagonism by two novel benzodiazepines.

27 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structure

27 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test

27 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821.

27 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

Animal models for the study of anti-anxiety agents: a review

27 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

A simple and reliable conflict procedure for testing anti-anxiety agents

27 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

The validity of animal models of depression

27 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

Pharmacological and behavioral profile of alpidem as an anxiolytic

27 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0278-5846(91)90082-C

27 October 2022

Identifiers

1 reference

14 August 2017

1 reference